Log In
Print this Print this

Magellan MAR01

  Manage Alerts
Collapse Summary General Information
Company Arteriocyte Inc.
DescriptionMedical device that concentrates aspirated bone marrow to yield injectable tissue rich in platelets, hematopoietic stem cells and mesenchymal stem cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentPhase I
Standard IndicationIschemia / reperfusion injury
Indication DetailsTreat critical limb ischemia (CLI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today